UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:SET-UTP11L |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: SET-UTP11L | FusionPDB ID: 80972 | FusionGDB2.0 ID: 80972 | Hgene | Tgene | Gene symbol | SET | UTP11L | Gene ID | 6418 | 51118 |
Gene name | SET nuclear proto-oncogene | UTP11 small subunit processome component | |
Synonyms | 2PP2A|I2PP2A|IGAAD|IPP2A2|MRD58|PHAPII|TAF-I|TAF-IBETA | CGI-94|CGI94|UTP11L | |
Cytomap | 9q34.11 | 1p34.3 | |
Type of gene | protein-coding | protein-coding | |
Description | protein SETHLA-DR-associated protein IISET nuclear oncogeneSET translocation (myeloid leukemia-associated)Template-Activating Factor-I, chromatin remodelling factorchromatin remodelling factorinhibitor of granzyme A-activated DNaseinhibitor-2 of pr | probable U3 small nucleolar RNA-associated protein 11U3 snoRNA-associated protein 11UTP11, small subunit processome component homologUTP11-like proteinUTP11-like, U3 small nucleolar ribonucleoprotein | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9BYW2 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000477806, ENST00000322030, ENST00000372688, ENST00000372692, ENST00000409104, | ENST00000373014, ENST00000537711, ENST00000488453, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 16 X 14 X 3=672 | 3 X 3 X 3=27 |
# samples | 17 | 4 | |
** MAII score | log2(17/672*10)=-1.98292648664106 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/27*10)=0.567040592723894 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: SET [Title/Abstract] AND UTP11L [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | SET(131453506)-UTP11L(38483340), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | SET-UTP11L seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. SET-UTP11L seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SET | GO:0045892 | negative regulation of transcription, DNA-templated | 19343227 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8078-01A | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000372692 | SET | chr9 | 131453506 | + | ENST00000373014 | UTP11L | chr1 | 38483340 | + | 2244 | 411 | 241 | 1047 | 268 |
ENST00000372692 | SET | chr9 | 131453506 | + | ENST00000537711 | UTP11L | chr1 | 38483340 | + | 1137 | 411 | 241 | 732 | 163 |
ENST00000409104 | SET | chr9 | 131453506 | + | ENST00000373014 | UTP11L | chr1 | 38483340 | + | 2022 | 189 | 85 | 825 | 246 |
ENST00000409104 | SET | chr9 | 131453506 | + | ENST00000537711 | UTP11L | chr1 | 38483340 | + | 915 | 189 | 85 | 510 | 141 |
ENST00000322030 | SET | chr9 | 131453506 | + | ENST00000373014 | UTP11L | chr1 | 38483340 | + | 2321 | 488 | 357 | 1124 | 255 |
ENST00000322030 | SET | chr9 | 131453506 | + | ENST00000537711 | UTP11L | chr1 | 38483340 | + | 1214 | 488 | 487 | 2 | 162 |
ENST00000372688 | SET | chr9 | 131453506 | + | ENST00000373014 | UTP11L | chr1 | 38483340 | + | 1931 | 98 | 0 | 734 | 244 |
ENST00000372688 | SET | chr9 | 131453506 | + | ENST00000537711 | UTP11L | chr1 | 38483340 | + | 824 | 98 | 0 | 419 | 139 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000372692 | ENST00000373014 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.000772628 | 0.9992274 |
ENST00000372692 | ENST00000537711 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.006297492 | 0.99370253 |
ENST00000409104 | ENST00000373014 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.001009723 | 0.99899024 |
ENST00000409104 | ENST00000537711 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.011314304 | 0.9886857 |
ENST00000322030 | ENST00000373014 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.000995171 | 0.9990049 |
ENST00000322030 | ENST00000537711 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.005525249 | 0.9944747 |
ENST00000372688 | ENST00000373014 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.00045038 | 0.99954957 |
ENST00000372688 | ENST00000537711 | SET | chr9 | 131453506 | + | UTP11L | chr1 | 38483340 | + | 0.005454534 | 0.99454546 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >80972_80972_1_SET-UTP11L_SET_chr9_131453506_ENST00000322030_UTP11L_chr1_38483340_ENST00000373014_length(amino acids)=255AA_BP=43 MSAPAAKVSKKELNSNHDGADETSEKEQQEAIEHIDEVQNEIDSDYRKKQEYLKALRKKALEKNPDEFYYKMTRVKLQDGVHIIKETKEE VTPEQLKLMRTQDVKYIEMKRVAEAKKIERLKSELHLLDFQGKQQNKHVFFFDTKKEVEQFDVATHLQTAPELVDRVFNRPRIETLQKEK -------------------------------------------------------------- >80972_80972_2_SET-UTP11L_SET_chr9_131453506_ENST00000322030_UTP11L_chr1_38483340_ENST00000537711_length(amino acids)=162AA_BP= MSISFCTSSMCSIASCCSFSEVSSAPSWLELSSFLLTLAAGADMVLLRGRGGSGEGERREGEGGGQAASPHATRAGARSVRPPPPGARSL -------------------------------------------------------------- >80972_80972_3_SET-UTP11L_SET_chr9_131453506_ENST00000372688_UTP11L_chr1_38483340_ENST00000373014_length(amino acids)=244AA_BP=32 MMPRSHQPPPPPHEKEQQEAIEHIDEVQNEIDSDYRKKQEYLKALRKKALEKNPDEFYYKMTRVKLQDGVHIIKETKEEVTPEQLKLMRT QDVKYIEMKRVAEAKKIERLKSELHLLDFQGKQQNKHVFFFDTKKEVEQFDVATHLQTAPELVDRVFNRPRIETLQKEKVKGVTNQTGLK -------------------------------------------------------------- >80972_80972_4_SET-UTP11L_SET_chr9_131453506_ENST00000372688_UTP11L_chr1_38483340_ENST00000537711_length(amino acids)=139AA_BP=32 MMPRSHQPPPPPHEKEQQEAIEHIDEVQNEIDSDYRKKQEYLKALRKKALEKNPDEFYYKMTRVKLQDGVHIIKETKEEVTPEQLKLMRT -------------------------------------------------------------- >80972_80972_5_SET-UTP11L_SET_chr9_131453506_ENST00000372692_UTP11L_chr1_38483340_ENST00000373014_length(amino acids)=268AA_BP=56 MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKGEKEQQEAIEHIDEVQNEIDSDYRKKQEYLKALRKKALEKNPDEFYYKMTRVKL QDGVHIIKETKEEVTPEQLKLMRTQDVKYIEMKRVAEAKKIERLKSELHLLDFQGKQQNKHVFFFDTKKEVEQFDVATHLQTAPELVDRV -------------------------------------------------------------- >80972_80972_6_SET-UTP11L_SET_chr9_131453506_ENST00000372692_UTP11L_chr1_38483340_ENST00000537711_length(amino acids)=163AA_BP=56 MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKGEKEQQEAIEHIDEVQNEIDSDYRKKQEYLKALRKKALEKNPDEFYYKMTRVKL -------------------------------------------------------------- >80972_80972_7_SET-UTP11L_SET_chr9_131453506_ENST00000409104_UTP11L_chr1_38483340_ENST00000373014_length(amino acids)=246AA_BP=34 MGCRDLLPSLKPTLLEKEQQEAIEHIDEVQNEIDSDYRKKQEYLKALRKKALEKNPDEFYYKMTRVKLQDGVHIIKETKEEVTPEQLKLM RTQDVKYIEMKRVAEAKKIERLKSELHLLDFQGKQQNKHVFFFDTKKEVEQFDVATHLQTAPELVDRVFNRPRIETLQKEKVKGVTNQTG -------------------------------------------------------------- >80972_80972_8_SET-UTP11L_SET_chr9_131453506_ENST00000409104_UTP11L_chr1_38483340_ENST00000537711_length(amino acids)=141AA_BP=34 MGCRDLLPSLKPTLLEKEQQEAIEHIDEVQNEIDSDYRKKQEYLKALRKKALEKNPDEFYYKMTRVKLQDGVHIIKETKEEVTPEQLKLM -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:131453506/chr1:38483340) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
SET | . |
FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-36' of histone H3 (H3K36me3) using dimethylated 'Lys-36' (H3K36me2) as substrate (PubMed:16118227, PubMed:19141475, PubMed:21526191, PubMed:21792193, PubMed:23043551, PubMed:27474439). It is capable of trimethylating unmethylated H3K36 (H3K36me0) in vitro (PubMed:19332550). Represents the main enzyme generating H3K36me3, a specific tag for epigenetic transcriptional activation (By similarity). Plays a role in chromatin structure modulation during elongation by coordinating recruitment of the FACT complex and by interacting with hyperphosphorylated POLR2A (PubMed:23325844). Acts as a key regulator of DNA mismatch repair in G1 and early S phase by generating H3K36me3, a mark required to recruit MSH6 subunit of the MutS alpha complex: early recruitment of the MutS alpha complex to chromatin to be replicated allows a quick identification of mismatch DNA to initiate the mismatch repair reaction (PubMed:23622243). Required for DNA double-strand break repair in response to DNA damage: acts by mediating formation of H3K36me3, promoting recruitment of RAD51 and DNA repair via homologous recombination (HR) (PubMed:24843002). Acts as a tumor suppressor (PubMed:24509477). H3K36me3 also plays an essential role in the maintenance of a heterochromatic state, by recruiting DNA methyltransferase DNMT3A (PubMed:27317772). H3K36me3 is also enhanced in intron-containing genes, suggesting that SETD2 recruitment is enhanced by splicing and that splicing is coupled to recruitment of elongating RNA polymerase (PubMed:21792193). Required during angiogenesis (By similarity). Required for endoderm development by promoting embryonic stem cell differentiation toward endoderm: acts by mediating formation of H3K36me3 in distal promoter regions of FGFR3, leading to regulate transcription initiation of FGFR3 (By similarity). In addition to histones, also mediates methylation of other proteins, such as tubulins and STAT1 (PubMed:27518565, PubMed:28753426). Trimethylates 'Lys-40' of alpha-tubulins such as TUBA1B (alpha-TubK40me3); alpha-TubK40me3 is required for normal mitosis and cytokinesis and may be a specific tag in cytoskeletal remodeling (PubMed:27518565). Involved in interferon-alpha-induced antiviral defense by mediating both monomethylation of STAT1 at 'Lys-525' and catalyzing H3K36me3 on promoters of some interferon-stimulated genes (ISGs) to activate gene transcription (PubMed:28753426). {ECO:0000250|UniProtKB:E9Q5F9, ECO:0000269|PubMed:16118227, ECO:0000269|PubMed:19141475, ECO:0000269|PubMed:21526191, ECO:0000269|PubMed:21792193, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:23325844, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:24509477, ECO:0000269|PubMed:24843002, ECO:0000269|PubMed:27317772, ECO:0000269|PubMed:27474439, ECO:0000269|PubMed:27518565, ECO:0000269|PubMed:28753426}.; FUNCTION: (Microbial infection) Recruited to the promoters of adenovirus 12 E1A gene in case of infection, possibly leading to regulate its expression. {ECO:0000269|PubMed:11461154}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000322030 | + | 2 | 8 | 239_290 | 43.666666666666664 | 278.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000372688 | + | 2 | 8 | 239_290 | 32.666666666666664 | 267.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000372692 | + | 2 | 8 | 239_290 | 56.666666666666664 | 291.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000409104 | + | 2 | 8 | 239_290 | 34.666666666666664 | 269.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000322030 | + | 2 | 8 | 31_78 | 43.666666666666664 | 278.0 | Region | Note=Dimerization |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000322030 | + | 2 | 8 | 79_225 | 43.666666666666664 | 278.0 | Region | Note=Earmuff domain |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000372688 | + | 2 | 8 | 31_78 | 32.666666666666664 | 267.0 | Region | Note=Dimerization |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000372688 | + | 2 | 8 | 79_225 | 32.666666666666664 | 267.0 | Region | Note=Earmuff domain |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000372692 | + | 2 | 8 | 31_78 | 56.666666666666664 | 291.0 | Region | Note=Dimerization |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000372692 | + | 2 | 8 | 79_225 | 56.666666666666664 | 291.0 | Region | Note=Earmuff domain |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000409104 | + | 2 | 8 | 31_78 | 34.666666666666664 | 269.0 | Region | Note=Dimerization |
Hgene | SET | chr9:131453506 | chr1:38483340 | ENST00000409104 | + | 2 | 8 | 79_225 | 34.666666666666664 | 269.0 | Region | Note=Earmuff domain |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
SET | |
UTP11L |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to SET-UTP11L |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to SET-UTP11L |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |